… an important role for estrogen (ER), progesterone (PR), and … Patients with tumors in which
more than 10% of cells had … 5-year survival = 51.9 months) than did patients with tumors in …

… review of scattergrams of the data comparing level of receptor to patient survival it was
noted that most patients with PR, levels below 10 fmol/mg of cytosolic protein did not survive. A …

… the expression of PR by the tumor cells may be associated with a shorter patient survival [8]. …
Kaplan-Meier survival curves of overall survival for the patients with CRC patients. a Internal …

… Estrogen (ER), progesterone (PR), and androgen receptors (AR) … cancer and correlated
with patient survival. The mean follow-up … Estrogen and progesterone receptor titers in primary …

… -free survival between the 117 triple-negative (basal-like) patients and the rest … survival
(94% for triple negative v 99% for all others; P = .05). In another study by Dent et al 12 of patients …

… patient survival. No statistically significant correlation was found between the presence or
absence of estrogen receptors (ER, 56.1%), progesterone … 33.3%) and survival. However, high …

… The greater overall survival of receptor-positive patients is mainly due to an increase in
survival … Estrogen receptor quantitation and staging as complementary prognostic indicators in …

… -free survival (DFS) for AIs over tamoxifen, with survival benefits evident in some trials [4].
Greater efficacy has also been recorded in the neoadjuvant setting [5, 6]. However, there is still …

… breast cancers with “weak” estrogen receptor (ER)/progesterone receptor (PR) expression
… the overall survival (OS), disease-free survival rates (DFS), and disease-specific survival (…

… recurrence-free survival (RFS) as well as survival can be related to receptor status (1—3).
However, it is still believed that the nodal status is the best prognostic parameter. In …